SCHEMBL3737360

SCHEMBL3737360

CCC(C(=O)O)(c1ccc(C)nc1C)N1CCN(C)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 3/20 0.35
HTR3E A5X5Y0 1/20 0.33
HTR3B O95264 1/20 0.33
HTR3A P46098 1/20 0.33
HTR3D Q70Z44 1/20 0.33
HTR3C Q8WXA8 1/20 0.33
ADORA2A P29274 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MLNR O43193 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HRH1 P35367 1/20 0.32
OPRM1 P35372 1/20 0.32
DRD3 P35462 1/20 0.32
OPRK1 P41145 1/20 0.32
HTR2B P41595 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3747740 0.81 CHIA (0.39) SSTR4KDM4EMLNRCHRM2CHRM1
SCHEMBL3748570 0.77 CHRM1 (0.34) ALDH1A1MLNRCHRM2CHRM1CHRM3
SCHEMBL3745963 0.71 HRH4 (0.37) KDM4EALDH1A1MEN1KMT2AHRH4
SCHEMBL3741710 0.70 SSTR4 (0.39) SSTR4KDM4EALDH1A1MEN1KMT2A
SCHEMBL3742807 0.70 CHRM1 (0.39) KDM4EALDH1A1MLNRCHRM2CHRM1
SCHEMBL3635401 0.65 MC4R (0.37) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL13044650 0.64 MC4R (0.42) OPRM1OPRK1KCNH2CYP2C9
SCHEMBL3741368 0.64 HTR3E (0.44) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL3747924 0.63 CHRM1 (0.38) MLNRCHRM2CHRM1CHRM3HTR2A
SCHEMBL25344626 0.62 CHRM1 (0.48) ALDH1A1CHRM1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R SSTR4 23/4885HTR3E 219/4885HTR3B 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.